Page last updated: 2024-08-23

phenyl acetate and Cholangitis

phenyl acetate has been researched along with Cholangitis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Mishra, AK; Singh, SP1
Bowlus, CL; Hirschfield, GM; Levy, C1
Bacon, BR; Bernstein, DE; Boudes, PF; Bowlus, CL; Buggisch, P; Chera, H; Choi, YJ; Clark, V; Corless, L; Doerffel, Y; Freilich, BL; Galambos, MR; Gitlin, N; Gordon, SC; Hartleb, M; Hartmann, H; Hirschfield, GM; Janczewska, E; Jonas, ME; Jones, D; Kremer, AE; Levy, C; Martin, R; McWherter, CA; Mells, GF; Odin, JA; Rochling, F; Shah, H; Sheridan, D; Shiffman, ML; Smith, JH; Steinberg, A; Swain, MG; Varga, M; Vierling, JM; Wörns, MA1
Szczeklik, A; Szewczuk, A1
Fischer, P; Reinelt, D1

Trials

1 trial(s) available for phenyl acetate and Cholangitis

ArticleYear
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study.
    The lancet. Gastroenterology & hepatology, 2017, Volume: 2, Issue:10

    Topics: Acetates; Adult; Aged; Alanine Transaminase; Cholangitis; Diarrhea; Double-Blind Method; Drug Administration Schedule; Female; Humans; Liver; Male; Middle Aged; Nausea; PPAR delta; Pruritus; Treatment Outcome; Triazoles; Ursodeoxycholic Acid

2017

Other Studies

4 other study(ies) available for phenyl acetate and Cholangitis

ArticleYear
Seladelpar in patients with primary biliary cholangitis: Need for a closer look!
    Journal of hepatology, 2022, Volume: 77, Issue:5

    Topics: Acetates; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid

2022
Reply to: "Seladelpar in patients with primary biliary cholangitis: Need for a closer look!"
    Journal of hepatology, 2022, Volume: 77, Issue:5

    Topics: Acetates; Cholangitis; Humans; Liver Cirrhosis, Biliary

2022
Cobalt-activated acylase in human serum. Occurrence in hepatobiliary diseases.
    Clinica chimica acta; international journal of clinical chemistry, 1971, Volume: 33, Issue:2

    Topics: Acetates; Acute Disease; Acyltransferases; Adolescent; Adult; Aged; Amides; Child; Chlorides; Chlorine; Cholangitis; Cholecystitis; Cholestasis; Chronic Disease; Cobalt; Dipeptides; Drug Stability; Enzyme Activation; Glutamates; Hepatitis; Hepatomegaly; Hodgkin Disease; Humans; Hydrogen-Ion Concentration; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Middle Aged; Naphthalenes; Temperature

1971
[Significance of the uranyl acetate test in the diagnosis of liver diseases].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1968, Jun-15, Volume: 23, Issue:12

    Topics: Acetates; Acute Disease; Blood Coagulation Tests; Blood Sedimentation; Cholangitis; Cholestasis; Chronic Disease; Cysts; Fatty Liver; Hepatitis; Humans; Hyperbilirubinemia; Indicators and Reagents; Liver Cirrhosis; Liver Diseases; Liver Neoplasms

1968